Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma

Clinical Chemistry

Volumn 60, Issue 9, 2014, Pages 1183-1191

  Potter, Nicholas T ^a   Hurban, Patrick ^b   White, Mary N ^a   Whitlock, Kara D ^a   Lofton Day, Catherine E ^c   Tetzner, Reimo ^d   Koenig, Thomas ^d   Quigley, Neil B ^a   Weiss, Gunter ^d  

^a Molecular Pathology Laboratory Network Inc   (United States)

^b IQVIA   (United States)

^c AMGEN INC   (United States)

^d EPIGENOMICS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COLONIC NEOPLASMS; DNA METHYLATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEPTINS;

EID: 84906828290     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.221044     Document Type: Article

References (40)

1. WHO Cancer Fact Sheet 2012. http://www.ho.int/wmediacentre/factsheets/ fs297/en/ (Accessed June 2014).
2. Siegel R, Naishadham MA, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
3. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130-60. (Pubitemid 351830299)
4. Kuipers EJ, Rösch T, Bretthauer M. Colorectal cancer screening: optimizing current strategies and new directions. Nat Rev Clin Oncol 2013;10:130-42.
5. Joseph DA, King JB, Miller JW, Richardson LC. Prevalence of colorectal cancer screening among adults: behavioral risk factor surveillance system, United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61 Suppl:51-6.
6. US Preventive Services Task Force Recommendation (2008): http://www.uspreventiveservicestaskforce.org/uspstf/uspscolo.htm (Accessed June 2014).
7. Moiel D, Thompson J. Early detection of colon cancer: the Kaiser Permanente northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients? Perm J 2011;4:30-8.
8. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1366-71.
9. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7. (Pubitemid 32162983)
10. Creeden J, Junker F, Vogel-Ziebolz S, Rex D. Serum tests for colorectal cancer screening. Mol Diagn Ther 2011;15:129-41.
11. Ahlquist DA, Zou H, Domanico M, Mahoney DW, Yab TC, et al. Next-generation stool DNA test accurately detects colorectal cancer and large adenomas. Gastroenterology 2012;142:248-56.
12. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011;11:426-37.
13. Oh T, Kim N, Moon Y, Kim MS, Hoehn BD, Park CH, et al. Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer. J Mol Diagn 2013;15:498-507.
14. Lange CP, Campan M, Hinoue T, Schmitz RF, van der Meulen-de Jong AE, et al. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer. PLoS One 2012;7:e50266.
15. Lofton-Day C, Model F, Devos T, Tetzner R, Distler J, Schuster M, et al. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008;54:414-23. (Pubitemid 351302625)
16. Wasserkort R, Kalmar A, Valcz G, Spisak S, Krispin M, Toth K, et al. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. BMC Cancer 2013;13:398.
17. LaPointe LC, Pedersen SK, Dunne R, Brown GS, Pimlott L, Gaur S, et al. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing. Plos One 2012;7:e29059.
18. Payne SR. From discovery to the clinic: the novel DNA methylation biomarker (m) SEPT9 for the detection of colorectal cancer in blood. Epigenomics 2010;2:575-85.
19. deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 2009;55:1337-46.
20. Hall PA, Russell SE. The pathobiology of the septin gene family. J Pathol 2004;204:489-505. (Pubitemid 39468160)
21. Connolly D, Abdesselam I, Verdier-Pinard P, Montagna C. Septin roles in tumorigenesis. Biol Chem 2011;392:725-38.
22. McDade SS, Hall PA, Russell SE. Translational control of SEPT9 isoforms is perturbed in disease. Hum Mol Genet 2007;16:742-52. (Pubitemid 47061621)
23. Ahmed D, Danielsen SA, Aagesen TH, Bretthauer M, Thiis-Evensen E, et al. A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors. Clin Transl Gastroenterol 2012;3:e27.
24. Grützmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, et al. Sensitive detection of colorectal cancer in peripheral blood by Septin 9 DNA methylation assay. PLoS One 2008;3:1-8.
25. Warren JD, Xiong W, Bunker AM, Vaughn CP, Furtado LV, Roberts WL, et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 2011;9:133.
26. Church TR, Wandell M, Lofton-Day C, Mongin, SJ, Burger M, Payne SR, et al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut 2014;63:317-25.
27. Tóth K, Sipos F, Kalmár A, Patai AV, Wichmann B, Stoehr R, et al. Detection of methylated SEPT9 in plasma is a reliable screening method for both left-and right-sided colon cancers. PLoS One. 2012;7:e46000.
28. R Core Team (2012). R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
29. Suzuki N, Kamataki A, Yamaki J, Homma Y. Characterization of circulating DNA in healthy human plasma. Clin Chim Acta 2008;387:55-8. (Pubitemid 350050929)
30. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204:205.e1-11.
31. Perkins G, Yap TA, Pope L, Cassidy AM, Dukes JP, Riisnaes R, et al. Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers. PLoS One 2012;7(11):e47020.
32. Coe SG, Wallace MB. Management of small and diminutive colorectal polyps: a review of the literature. Minerva Gastroenterol Dietol 2011;57:167-76.
33. Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, et al. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clin Cancer Res 2010;16:3539-47.
34. Johnson DA, Barclay RL, Mergener K, Weiss G, König T, Beck J, Potter NT. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. PLoS One 2014;9:e98238.
35. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8. (Pubitemid 41096630)
36. Young PE, Womeldorph CM. Colonoscopy for colorectal cancer screening. J Cancer 2013;4:217-26.
37. Ladabaum U, Allen J, Wandell M, Ramsey SD. Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated Septin 9 DNA vs. current strategies. Cancer Epidemiol Biomarkers Prev 2013;22:1567-76.
38. Calonge N, Petitti DB, DeWitt TG, Dietrich AJ, Gregory KD, Harris R, et al. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.
39. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al.; ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.
40. Inadomi JM, Vijan S, Janz NK, Fagerlin A, Thomas JP, Lin YV, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med 2012;172:575-82.